戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rphology to predict the biologic behavior of Hurthle cell carcinoma.
2 papillary and follicular subtypes but not in Hurthle cell carcinoma.
3 ion and clinical management of patients with Hurthle cell carcinoma.
4                  All patients had documented Hurthle cell carcinoma.
5 may be useful for diagnosing widely invasive Hurthle cell carcinomas.
6 but also in papillary thyroid carcinomas and Hurthle cell carcinomas.
7 inomas, 0 of 40 follicular adenomas, 1 of 30 Hurthle cell carcinomas, 1 of 90 papillary carcinomas, a
8 inomas, 9 were anaplastic carcinomas, 5 were Hurthle cell carcinomas, 21 were nonfunctioning follicul
9 conduct a critical histopathologic review of Hurthle cell carcinoma and to correlate morphologic para
10 d surgeons recommend total thyroidectomy for Hurthle cell carcinomas and reserve thyroid lobectomy fo
11 in the clinically aggressive widely invasive Hurthle cell carcinomas and was associated with signific
12 s predict a worse outcome in widely invasive Hurthle cell carcinoma, as does extrathyroidal extension
13                                              Hurthle cell carcinoma demonstrates intense uptake on (1
14                       However, patients with Hurthle cell carcinomas had significantly larger tumors
15                                Patients with Hurthle cell carcinoma have a prognosis that is predicte
16                                     However, Hurthle cell carcinomas have a unique genomic landscape
17                                              Hurthle cell carcinomas (HCCs) display two exceptional g
18 ions exist for follicular thyroid cancer and Hurthle cell carcinoma in evidence-based guidelines.
19  in FTCs, including insular type tumors, and Hurthle cell carcinomas in comparison with normal thyroi
20                                              Hurthle cell carcinoma is an uncommon and occasionally a
21                                              Hurthle cell carcinoma is an uncommon differentiated thy
22 ciated with the diagnosis of widely invasive Hurthle cell carcinoma (P < 0.001).
23 tion and disease management in patients with Hurthle cell carcinoma relative to anatomic or iodine im
24 h (18)F-FDG PET in the care of patients with Hurthle cell carcinoma to determine the likelihood of up
25 imally (n = 14) and widely (n = 21) invasive Hurthle cell carcinomas were arrayed in triplicate on ti